日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy

SITC愿景:调整临床试验以加速癌症免疫疗法药物的研发

Marron, Thomas U; Luke, Jason J; Hoffner, Brianna; Perlmutter, Jane; Szczepanek, Connie; Anagnostou, Valsamo; Silk, Ann W; Romero, Pedro J; Garrett-Mayer, Elizabeth; Emens, Leisha A

Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols

癌症免疫治疗学会 (SITC) 关于免疫治疗临床方案关键生物标志物的共识声明

Cottrell, Tricia R; Lotze, Michael T; Ali, Alaa; Bifulco, Carlo B; Capitini, Christian M; Chow, Laura Q M; Cillo, Anthony R; Collyar, Deborah; Cope, Leslie; Deutsch, Julie Stein; Dubrovsky, Genia; Gnjatic, Sacha; Goh, Denise; Halabi, Susan; Kohanbash, Gary; Maecker, Holden T; Maleki Vareki, Saman; Mullin, Sarah; Seliger, Barbara; Taube, Janis; Vos, Wim; Yeong, Joe; Anderson, Kristin G; Bruno, Tullia C; Chiuzan, Codruta; Diaz-Padilla, Ivan; Garrett-Mayer, Elizabeth; Glitza Oliva, Isabella C; Grandi, Paola; Hill, Elizabeth G; Hobbs, Brian P; Najjar, Yana G; Pettit Nassi, Phyllis; Simons, Virgil H; Subudhi, Sumit K; Sullivan, Ryan J; Takimoto, Chris H

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols

SPIRIT-DEFINE 解释和阐述:提高早期剂量探索临床试验方案质量和影响的建议

Ursino, Moreno; Villacampa, Guillermo; Rekowski, Jan; Dimairo, Munyaradzi; Solovyeva, Olga; Ashby, Deborah; Berlin, Jordan; Boix, Oliver; Calvert, Melanie; Chan, An-Wen; Coschi, Courtney H; Evans, Thomas R Jeffry; Garrett-Mayer, Elizabeth; Golub, Robert M; Guo, Christina; Hayward, Kathryn S; Hopewell, Sally; Isaacs, John D; Ivy, S Percy; Jaki, Thomas; Kholmanskikh, Olga; Kightley, Andrew; Lee, Shing; Liu, Rong; Mander, Adrian; Marshall, Lynley V; Matcham, James; Patel, Dhrusti; Peck, Richard; Rantell, Khadija Rerhou; Richards, Dawn P; Rouhifard, Mahtab; Seymour, Lesley; Tanaka, Yoshiya; Weir, Christopher J; de Bono, Johann; Yap, Christina

CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials

CONSORT-DEFINE 解释和阐述:提高早期剂量探索临床试验报告质量和影响的建议

Rekowski, Jan; Guo, Christina; Solovyeva, Olga; Dimairo, Munyaradzi; Rouhifard, Mahtab; Patel, Dhrusti; Alger, Emily; Ashby, Deborah; Berlin, Jordan; Boix, Oliver; Calvert, Melanie; Chan, An-Wen; Coschi, Courtney H; de Bono, Johann; Evans, Thomas R Jeffry; Garrett-Mayer, Elizabeth; Golub, Robert M; Hayward, Kathryn S; Hopewell, Sally; Isaacs, John D; Ivy, S Percy; Jaki, Thomas; Kholmanskikh, Olga; Kightley, Andrew; Lee, Shing; Liu, Rong; Maia, Israel; Mander, Adrian; Marshall, Lynley V; Matcham, James; Peck, Richard; Rantell, Khadija Rerhou; Richards, Dawn P; Seymour, Lesley; Tanaka, Yoshiya; Ursino, Moreno; Weir, Christopher J; Yap, Christina

Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

阿法替尼治疗伴有神经调节蛋白1 (NRG1) 融合的实体瘤患者:来自靶向药物和谱系分析应用注册研究 (TAPUR) 的病例系列

Rodon, J; Rothe, M; Mangat, P K; Garrett-Mayer, E; Cannon, T L; Hobbs, E; Kalemkerian, G P; Hinshaw, D C; Gregory, A; Grantham, G N; Halabi, S; Schilsky, R L

Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR)

COVID-19 对肿瘤患者管理和预后的影响:MENA COVID-19 和癌症登记处 (MCCR) 的结果

Jazieh, Abdul-Rahman; Bounedjar, Adda; Abdel-Razeq, Hikmat; Berna Koksoy, Elif; Ansari, Jawaher; Tfayli, Arafat H; Tashkandi, Emad M; Jastaniah, Wasil A; Alorabi, Mohamed Osama; Darwish, Amira D; Rabea, Ahmed Magdy; Al Olayan, Ashwaq; Ibnshamsah, Fahad; Errihani, Hassan; AlKaiyat, Mohammad Omar; Hussain, Fazal; Alkattan, Khaled; Bruinooge, Suanna Steeby; Garrett-Mayer, Elizabeth; Tamim, Hani

107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis

107P COVID-19 大流行对乳腺癌新辅助治疗的影响:一项回顾性机构分析

Schmidt, M; Untch, M; Jazieh, AR; Abdel-Razeq, H; Köksoy, EB; Bounedjar, A; Tafayli, A; Tashkandi, E; Jastaniah, W; Ansari, J; Alorabi, MO; Darwish, AD; Rabea, A; Alolayan, AAM; Ibnshamsa, F; Errihani, H; Alkaiyat, M; Garrett-Mayer, E; Bruinooge, SS; Hussain, F; Tamim, H; AlKattan, K; Baptista Freitas, MC; Lopes de Almeida, C; Valente, AC; Costa, MJ; Nogueira Costa, IC; Reis, JS; Tavares, NT; Dionísio de Sousa, IJ; Almeida, DPS; Caeiro, CLB; Augusto, IM; Nunes Aguas, LM; Barbosa, M

Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress

疫情期间临床证据的生成:为持续取得进展而汲取的经验教训

Rivera, Donna R; Kluetz, Paul G; Abdallah, Kald; Agrawal, Sundeep; Angus, Derek C; Califf, Robert M; Garrett-Mayer, Elizabeth; Hyer, Randall; Lowy, Douglas R; Khleif, Samir N

Explicit underdose control based on toxicity: Four points to consider

基于毒性的明确剂量不足控制:需要考虑的四个方面

Frankel, Paul H; Garrett-Mayer, Elizabeth; Krailo, Mark D

Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations

利用真实世界数据增强癌症试验的对照组:混合对照组方法及注意事项

Tan, W Katherine; Segal, Brian D; Curtis, Melissa D; Baxi, Shrujal S; Capra, William B; Garrett-Mayer, Elizabeth; Hobbs, Brian P; Hong, David S; Hubbard, Rebecca A; Zhu, Jiawen; Sarkar, Somnath; Samant, Meghna